Onconase and proteasome inhibitors have synergistic antitumor activity, even in resistant tumors Oct. 8, 1998 No Comments
ADIR presents two new series of ellipticine derivatives with improved profiles Oct. 7, 1998 No Comments
Antitumor agents with high potency and selectivity under evaluation at Shionogi Oct. 6, 1998 No Comments
FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder Oct. 5, 1998 No Comments
Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika Oct. 1, 1998 No Comments
IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis Sep. 30, 1998 No Comments